Lumira Ventures — 2020 Investments
2 investments dated 2020 · listed companies and verified rows first · show all
Develops regenerative therapy for persistent smell loss, currently in Phase 2 clinical trials.
HealthtechWashington, US
Richard Geoffrion(Executive Officer, Director)Robert Henkin(Director)
BoardTakahide Koda(Director)
Board seatGerry Brunk· per SEC Form D
Co-investorsRemiges Ventures, Inc.DeepWork Capital
BiotechVerdun
Stephen Nelson(Director)Adele Gulfo(Director)Ken d'Entremont(Executive Officer, Director)Roland Boivin(Executive Officer)Terri Shoemaker(Executive Officer)Michael Mueller(Director)
Board seatPeter van der Velden· per SEC Form D · $400K raise · filed Mar 2020
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.